Tabacum-Injeel Liq (12d,30d,200d/1.1ml) 12 D / 1.1 mL Liquid is a Health Canada–registered human drug (DIN 02065304) held by Biologische Heilmittel Heel GmbH, containing Nicotine. Health Canada lists its status as Cancelled Post Market (status date 10 Mar 1997). Nexara Health has matched 1262 registrations of Nicotine across 21 other regulated markets.

Health Canada registration

Nicotine registered in other markets

1262 registrations of the same molecule in 21 national registries outside Canada (first 120 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Nicotine worldwide →

Regulator price references for Nicotine

Published list or reimbursement prices for Nicotine presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Tabacum-Injeel Liq (12d,30d,200d/1.1ml) (DIN 02065304) marketed in Canada?

No. Health Canada lists DIN 02065304 as Cancelled Post Market as of 10 Mar 1997.

Who holds the Canadian licence for this product?

Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.

Is Nicotine registered outside Canada?

Yes — Nexara Health has matched 1262 registrations in 21 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02065304, status date 1997-03-10; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EU national register, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NPRA, PBS, SFDA, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, NHRA, PBS, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02065304, status date 1997-03-10; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EU national register, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NPRA, PBS, SFDA, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, NHRA, PBS, SFDA.

Health Canada Drug Product Database (DPD), DIN 02065304, status date 1997-03-10; national medicine registries: ANMDMR nomenclator, BDA, CNOPS liste des medicaments, DH Drug Office, DoH SEP database, EU national register, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHRA, NPRA, PBS, SFDA, SUKL DLP, URPL RPL; price sources: CNOPS liste des medicaments, DoH SEP database, EDE, NHRA, PBS, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.